![Jimmy Lucchesi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Jimmy Lucchesi is currently the Chief Operating Officer & Director at BonAlive Biomaterials Oy.
He previously worked as the Manager-Business Development at Vivoxid Oy.
Jimmy Lucchesi active positions
Companies | Position | Start |
---|---|---|
BonAlive Biomaterials Oy
![]() BonAlive Biomaterials Oy Medical SpecialtiesHealth Technology BonAlive Biomaterials Oy is a holding company that provides solutions to heal patients with bone defects. It develops synthetic biomaterial solutions for the treatment of chronically infected bone. Their products include BonAlive granules and BonAlive putty, which are osteostimulative; BonAlive granules, which inhibits bacterial growth and act as tool for bone cavity filling in the treatment of chronic osteomyelitis; and BonAlive plates, which have been designed for repair of orbital floor trauma. The company was founded by Fredrik Viktor Ollila on November 13, 2009 and is headquartered in Turku, Finland. | Chief Operating Officer | 31/12/2009 |
Former positions of Jimmy Lucchesi
Companies | Position | End |
---|---|---|
Vivoxid Oy
![]() Vivoxid Oy BiotechnologyHealth Technology Vivoxid Oy develops, manufactures and markets biomaterial products and production services within the medical device sector. The company was founded on January 14, 2002 and is headquartered in Helsinki, Finland. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Vivoxid Oy
![]() Vivoxid Oy BiotechnologyHealth Technology Vivoxid Oy develops, manufactures and markets biomaterial products and production services within the medical device sector. The company was founded on January 14, 2002 and is headquartered in Helsinki, Finland. | Health Technology |
BonAlive Biomaterials Oy
![]() BonAlive Biomaterials Oy Medical SpecialtiesHealth Technology BonAlive Biomaterials Oy is a holding company that provides solutions to heal patients with bone defects. It develops synthetic biomaterial solutions for the treatment of chronically infected bone. Their products include BonAlive granules and BonAlive putty, which are osteostimulative; BonAlive granules, which inhibits bacterial growth and act as tool for bone cavity filling in the treatment of chronic osteomyelitis; and BonAlive plates, which have been designed for repair of orbital floor trauma. The company was founded by Fredrik Viktor Ollila on November 13, 2009 and is headquartered in Turku, Finland. | Health Technology |
- Stock Market
- Insiders
- Jimmy Lucchesi